The field of cancer treatment, especially that of lung cancer, is rapidly evolving. Nowadays, new advances in techniques and medicines are turning lung cancer diagnoses into something less lethal. Dr. Anand Sachithanandan, a consultant cardiothoracic surgeon and Dr. Tho Lye Mun, our consultant clinical oncologist at Beacon Hospital, discuss the advent of personalized medicine and what it means for the future of lung cancer treatment.
For some private hospitals, running at a loss may be expected. But for Beacon Hospital, it lost over RM100 million to provide affordable cancer treatment. This is because the hospital, according to its executive director, Mary Chen, wants to provide health care access, particularly cancer treatment, to all Malaysians — especially those who can’t afford it.
Patients who have asked Mary Chen what she does at Beacon Hospital often do a double take when they find out that she is the founder. But the homely association is not surprising as those warded at the cancer specialist hospital would have met executive director Chen as she goes on her daily rounds after office hours, to chat with and comfort patients, often lending them a shoulder to cry on, as she empathizes with the patients.
Lung cancer is often mistaken as a smoker’s disease, so many non-smokers take it lightly and mistakenly believe that they are not at risk. These wrong concepts about lung cancer need to be corrected to recognize its true severity. The best way to spread this knowledge is by educating the patients, caregivers and medical professionals about lung cancer.
Koh yang berusia 79 tahun, disahkan menghidap kanser paru-paru tahap empat pada tahun 2017. Namun begitu, Koh menerimanya dengan tenang sambil berusaha mendapatkan rawatan pakar. Dia ingin membuktikan anggapan kanser adalah penamat kehidupan adalah tidak tepat. Dia pernah disahkan menghidap kanser payudara tahap satu pada tahun 2000 namun oleh kerana rawatan awal dilakukan membuatkan sel kanser tidak cepat merebak dan pulih sepenuhnya.